Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 13 clinical trials
Cilostazol for HFpEF

Determine if cilostazol improves symptoms and NTproBNP levels (heart failure blood marker) in heart failure with preserved ejection fraction (HFpEF) - a prevalent syndrome without targeted

  • 0 views
  • 26 Nov, 2021
  • 1 location
Cilostazol and Nimodipine Combined Therapy After Aneurysmal Subarachnoid Hemorrhage (aSAH)

The investigators seek to demonstrate that the combined use of cilostazol and nimodipine will significantly decrease the rate of delayed cerebral infarction and cerebral vasospasm after

  • 2 views
  • 21 Mar, 2022
  • 1 location
Efficacy of Cilostazol in Prevention of Peripheral Neuropathy

phosphodiesterase inhibitors, which increase the intracellular cAMP level, could prevent paclitaxel-induced dedifferentiation of Schwann cells. At the preclinical level, cilostazol potently inhibited paclitaxel

cancer
paclitaxel
  • 0 views
  • 13 May, 2022
  • 1 location
Efficacy and Safety of Cilostazol in Patients of Vascular Cognitive Impairment-no Dementia (VCIND)

Patients of vascular cognitive impairment-no dementia (VCIND) in one group is prescribed cilostazol,in the other group is prescribed aspirin. Evaluate both of them in cognitive function

  • 9 views
  • 07 Nov, 2020
  • 1 location
Evaluation the Safety and Efficacy of Cilostazol in Treatment of Patients With Fatty Liver Disease

The aim of the current study is to evaluate the safety and efficay of cilostazol in treatment of patients with fatty liver disease. Several previous reports have shown that cilostazol

  • 0 views
  • 16 Mar, 2022
  • 1 location
Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

The study is designed to evaluate the bioequivalence and the within-subject variability between the test formulation of extended-release tablet of cilostazol (PMR) administered once daily and

Accepts healthy volunteers
  • 0 views
  • 24 Mar, 2022
  • 1 location
The Phosphodiesterase 3 Inhibitor Cilostazol as an Adjunct to Conventional Therapy in Patients With Osteoarthritis

Cilostazol is able to suppress the degradation of type II collagen in human chondrocytes induced by IL-1b. Cilostazol add-on for celecoxib therapy has synergistic anti-arthritic potential by

  • 0 views
  • 15 May, 2022
  • 1 location
The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients

A randomized, double-blind, placebo-controlled, parallel study to investigate the effect of erenumab in calcitonin-gene related peptide and cilostazol experimental models of migraine in humans

erenumab
cilostazol
headache
calcitonin
calcitonin gene-related peptide
  • 24 views
  • 26 Jan, 2021
  • 1 location
Retina is a Marker for Cerebrovascular Heath

progression. This study aims to test whether impaired cerebral and retinal vasoreactivity may serve as biomarker for SVD progression, and to evaluate the safety and efficacy of cilostazol (antiplatelet agent

Accepts healthy volunteers
  • 0 views
  • 22 Mar, 2022
  • 1 location
VIRTUOSE : Efficiency of Sildenafil on the Absolute Claudication Distance of Peripheral Arterial Disease Patients With Intermittent Claudication.

consistent evidence for functional improvement in claudication, except for Cilostazol, a type-3 phospho-diesterase inhibitor (PDEi). This compound has been scarcely used in France due to cost and frequent

  • 0 views
  • 13 Dec, 2021
  • 2 locations